Genelux GNLX
NASDAQ GNLX
$2.07 -0.43 (-17.20%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genelux (GNLX) EBT Margin (2022 - 2024)

Updated

Genelux (GNLX) recorded EBT Margin of -406287.50% in FY2025, down 18837.50 percentage points from -387450.00% in FY2024.

Analysis

Genelux (GNLX) EBT Margin (2022 - 2024) Analysis & Trends

Starting with FY2022, Genelux's EBT Margin history includes 4 years.

  • Annual EBT Margin has declined for three straight years, with a three-year change of -406260.28 percentage points (FY2022 to FY2025).
  • Per Business Quant data, GNLX's EBT Margin was -387450.00% in FY2024 (-373357.65 pp), -14092.35% in FY2023 (-14065.13 pp) and -27.22% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 26.66%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 25.18%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 18.19%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -131.41%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -4.34%
10 Genelux 91.17 Mn 29.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -98,125.00%
Mar 31, 2023 -3,885.29%
Dec 31, 2022 -4,550.00%
Sep 30, 2022 54.63%
API Access

Genelux EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=GNLX&period=max&api_key=YOUR_API_KEY